risk factor for: Systemic lupus erythematosus, Sjögrens disease, Multiple Sclerosis, Crohns disease, and ulcerative colitis as determined by genome wide association studies (GWAS). The presence of this indel changes…
rectal medication is the acknowledged first line treatment for mild to moderate active ulcerative colitis and other gastrointestinal disease and ailments. Yet, patient compliance with prescribed rectal medication is…
risk and severity of GI infection and inflammation, including diarrheoa, inflammatory bowel disease, and ulcerative colitis as well as bowel function disorders, including irritable bowel syndrome. Furthermore prebiotics…
colorectal carcinoma (CRC). Material and methods: This study enrolled 85 cases: control 10, ulcerative colitis (UC) with and without dysplasia 3 and 7, Crohn?s disease (CD) 10, bilharzial colitis
children and adolescents with the disease. Crohn disease was responsible for 62.7% of cases, ulcerative colitis for 31.4% and indeterminate colitis for 5.9%. Considering the 4 different periods of time
study included 85 children, 45% with Crohn’s disease (CD) and 55% with ulcerative colitis (UC), and 31 adults with IBD. TPMT activity was measured with radiochemistry. TPMT
treatment of local diseases associated with the colon like Crohn’s disease, ulcerative colitis, etc. but also for the systemic delivery of proteins, therapeutic peptides, anti-asthmatic drugs, antihypertensive drugs
chronic inflammatory disorder of the bowel represented by two major forms; Ulcerative colitis (UC) and Crohn's disease (CD). Although the idiopathic nature of the disease, it's manifestations
Myocardial Infarction (AMI), prophylaxis against graft vs. host disease (GVHD) and in treatment of ulcerative colitis in an ongoing Phase II study with Pfizer. Athersys and collaborators have performed focused
guar gum and pectin as a carriers in the treatment of crohn’s disease, ulcerative colitis, colorectal cancer, etc. Fast-disintegrating methotrexate core tablets were compression-coated with different ratios
Inflammatory bowel disease (IBD) is a chronic relapsing and remitting disease that includes ulcerative colitis (UC) and Crohn’s disease (CD). It affects the population in a bimodal distribution with
were significantly higher in the IBD cases compared to the controls. In ulcerative colitis, the expression of COX-2 and co-expression of COX-2 and CD45 were greater than
have been much less promising. While there is suggestion of benefit when patients with ulcerative colitis use bacterial therapies small sample sizes and methodological weeknesses in study designs necessitate that
application of MRI in colorectal cancer, inflammatory bowel disease (Crohn’s disease and ulcerative colitis) and acute abdominal pain. The latter concerns MRI without a specific preparation while the other
indication of primary operation was low rectal cancer in 12 (80%) patients and ulcerative colitis in 3 (20%) patients. Management was successful in 12 (80%) patients leading to preservation
cases: The first case is a 32 years old male patient, known case of ulcerative colitis on Mesalamine, presented because of watery diarrhea, initial investigation were suggestive of TTP (high
chronic inflammation of entire gastrointestinal tract, which include the conditions like Ulcerative Colitis (UC) and Crohn?s disease which upon untreated leads to life threatening complication termed as colorectal cancer
Preventive and therapeutic effects of blueberry (Vaccinium corymbosum) extract against DSS-induced ulcerative colitis by regulation of antioxidant and inflammatory mediators. J Nutr Biochem
comparing to 50% survival rate in untreated group, remarkable protecting effect on Ulcerative Colitis, and profound result on preserving the fertility of mice at an Advanced Age. PDF HTML
Verspaget H W and Iliopoulos D (2015) Therapeutically targeting miR-214 circuit in ulcerative colitis and colitis-associated colon cancer. Gastroenterology 149(4):981-992. 3. Chen X, Iliopoulos
therapeutic potential of Brugia malayi recombinant cystatin (rBmCys) in immune-mediated disorders such as, ulcerative colitis (UC) and Type-1 diabetes (T1D) in rodent models. The anti-inflammatory activity
highly desirable for local treatment of a variety of bowel diseases such as ulcerative colitis, crohnâÂ?Â?s disease. The use of nanoparticular systems for the delivery of therapeutic agents
Inflammatory bowel diseases (IBD); Crohn’s disease and ulcerative colitis (UC), are idiopathic, intestinal and systemic inflammatory disorders which are immunologically mediated with activation of plasma proteolytic…
includes common and necessary conditions like colon polyps and cancer, hepatitis, reflux (heartburn), ulceration malady, colitis, vesica and biliary tract malady, organic process issues, Irritable gut Syndrome (IBS)…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.